Publicaciones en colaboración con investigadores/as de Tel Aviv University (132)

2023

  1. Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHT

    International Journal of Cardiology, Vol. 383, pp. 24-32

  2. COVID-19 infection in patients on long-term home parenteral nutrition for chronic intestinal failure

    Clinical Nutrition ESPEN, Vol. 55, pp. 212-220

  3. Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma

    New England Journal of Medicine, Vol. 389, Núm. 4, pp. 335-347

  4. Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion (American Journal of Clinical Dermatology, (2023), 24, 1, (5-14), 10.1007/s40257-022-00732-w)

    American Journal of Clinical Dermatology

  5. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023

    European Journal of Cancer, Vol. 195

  6. ESPEN practical and partially revised guideline: Clinical nutrition in the intensive care unit

    Clinical Nutrition, Vol. 42, Núm. 9, pp. 1671-1689

  7. Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel

    Journal of Medical Genetics, Vol. 60, Núm. 12, pp. 1186-1197

  8. Extreme deviations from the normative model reveal cortical heterogeneity and associations with negative symptom severity in first-episode psychosis from the OPTiMiSE and GAP studies

    Translational Psychiatry, Vol. 13, Núm. 1

  9. I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

    Clinical Gastroenterology and Hepatology, Vol. 21, Núm. 3, pp. 771-788.e10

  10. Implementation of the ESPEN guideline on clinical nutrition in the intensive care unit (ICU): It is time to move forward!: A position paper from the ‘nutrition in the ICU’ ESPEN special interest group

    Clinical Nutrition ESPEN, Vol. 57, pp. 318-330

  11. Levodopa–carbidopa intestinal gel in advanced Parkinson’s disease: long-term results from COSMOS

    Journal of Neurology, Vol. 270, Núm. 5, pp. 2765-2775

  12. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

    European Urology